DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Loibl S, Untch M, Burchardi N. et al.
Randomized phase II neoadjuvant study (GeparNuevo) to investigate the addition of durvalumab to a taxane-anthracycline containing chemotherapy in triple negative breast cancer.
ASCO J Clin Oncol 2018;
36 (Suppl.) Abstr. 104
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.